In contrast, a growing body of evidence indicated a positive correlation between elevated plasma apolipoprotein H (Apo-H; also known as β2-glycoprotein I) and apolipoprotein J (Apo-J; also referred to as clusterin) concentrations and the incidence of metabolic syndrome and associated systemic inflammation [17,18]. This evidence concerns the gene APOH and metabolic syndrome.